Keep it real
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
bizar, I get the SA pro page.
Can you copy paste please ?
It's a pro article
General public can read tomorrow, myself included :)
I observe most people fail to realize that the chart analysis is always about technical trading patterns. At the moment AVXL is stuck in such a mode: the share price is solely driven by market makers/manipulators driving it up and down, testing resistance and support levels,...
This pattern is to continue until fundamental news is released (eg full p2 data). That will then reset all the technical trading patterns.
It's as attractive at .5 or .4
Herceptin market is huge
P2 trial initiation soon
You'll find that the 'smaller' the small cap, the less it is influenced by general stock market behaver. Science and data is what drive them, big up or big down.
thanks for sharing Ahab!
Another tiny meaningless trial i guess? ...
Thanks for sharing Titan, but fundamentally I do not like these articles and here is why:
Holding: Long Position
Disclosure: SmallCap Network has been compensated $7,000 by Avenaddy, Inc. for market awareness and other advertising services on ONCS.
I believe the science will be good enough to do its own selling. Just look at INO, they are now up to +/- 45% tutes ownership. Hopefully ONCS will follow in their tracks.
I guess that means our institutional holders are not concerned.
Jimmy Carter announced melanoma cancer with spots on the brain. He will be treated with Keytruda (but also radiation)
Sounds like he needs to enroll in the combotrial?
You have misinterpreted the SEC fillings. These were not purchases in the open market but rather granting of stock options to employees. It gives them the right to purchase a certain amount of shares at a predetermined price of 0.28$
Of the Shares subject to the Option, 25% shall vest immediately upon August 18, 2015, and 1/36 of the remaining unvested Shares subject to the Option shall vest on each of the next thirty-six (36) monthly anniversaries
So they could buy 25% now, which none have done, and then at later timeframes.
Let me know where you are filing and we can make it an Oncosec-meet up
Lets just say that Dante has a better way with words ;)
If only I had the guts to play their game and sell and buy back lower. Bit in time I'm out I feel anxious and naked, so I keep my shares and just add on dips.
Remember when you were reporting on your telephone conversations with Punit and how good you were feeling about this stock? Has anything fundamentally changed science wise since that period late last year early this year? I do not think so. And yes it has all taken a little longer then we all hoped it would.
Just pre-empting: initial data release will be at least 12 weeks away, lets say 16-weeks to take data crunching into consideration.
You keep repeating the same statement and it has been discussed many times before. Use the search function
Going back and look for replies that were given to this statement of yours
P2 initiation expected in q3?
Great, at last one would say
So now 12 weeks to get 1st data, add another month to process, so that would mean earliest earliest opportunity to release data would be then mid-December?
how about you spend 5 minutes on google:
Fast Track
Determining whether a condition is serious is a matter of judgment, but generally is based on whether the drug will have an impact on such factors as survival, day-to-day functioning, or the likelihood that the condition, if left untreated, will progress from a less severe condition to a more serious one. AIDS, Alzheimer’s, heart failure and cancer are obvious examples of serious conditions. However, diseases such as epilepsy, depression and diabetes are also considered to be serious conditions.
Filling an unmet medical need is defined as providing a therapy where none exists or providing a therapy which may be potentially better than available therapy.
Then again could be SNGX too
Oh wasn't it going to break through 7?
I can only hope that when he does it will be again a buy signal to the shareholders saying that good news is imminent
You are kidding I presume?
I am ready again at .98 and lower :)
Read you five
I definatly hope he knows more than we do! If not we're in the shit
We had an update last Friday. The start is postponed to Q4. No reason given.
I have been in for 2 years and add on dips. Two weeks ago at 7, today at 7.25.
One day the market will see the light
They made there profit on day one
Pumping circus gone quiet. Some reappeared at AVXL in recent weeks
As you said over the weekend: one cannat proof what doesnt exist
Exactly!
So there is a pattern here of pushed out failures all trying to tell the workd they'r off for a challenge and we stupid scuckers buy that shit
Scary!
I've read it before on so many other biotech boards that their company is gonna beat cancer
So far cancer beat them all
That makes me a little more cautious in making grand statements ;) One step at a time, one partnership at a time, lets build.
Rome wasnt made in a day
But surely pushed out by drK?
In that case show us the proof
Dont blame anyone but yourself for poor investment decisions!
Dreaming is nice but lets keep it realistic and take the $10 pps corner first :)
Well Punit was CFO at Inovio, so there is a pattern of resigning CFO's to seek other challenges.
The part where you describe it as discarded technology is your interpretation only.